Hepatitis C Articles (HCV)
Back
	New HCV AASLD IDSA Guidelines Update Sept 21 2017: New Treatment-Naive & Treatment-Experienced Guidance / Genotype 1 & Genotype 3       http://hcvguidelines.org/   http://hcvguidelines.org/contents   http://hcvguidelines.org/announcements/09212017-0000/what’s-new-updates-and-changes-guidance   ° This version of the guidance has been updated to reflect several important developments, including the recent approvals of glecaprevir/pibrentasvir and sofosbuvir/velpatasvir/voxilaprevir. Updated recommendations reflecting these approvals are provided throughout the guidance.   ° In addition to updates to all the sections, the following new sections have been added to the Guidance:   ° HCV Resistance Primer   ° Kidney Transplant Patients   ° HCV in Pregnancy   ° HCV in Children   http://hcvguidelines.org/treatment-naive/gt1a/no-cirrhosis http://hcvguidelines.org/treatment-naive/gt1a/compensated-cirrhosis http://hcvguidelines.org/treatment-experienced/gt1/non-ns5a/compensated-cirrhosis http://hcvguidelines.org/treatment-experienced/gt1/ns5a http://hcvguidelines.org/treatment-experienced/gt1/ns3/without-cirrhosis http://hcvguidelines.org/treatment-experienced/gt1/ns3/compensated-cirrhosis http://hcvguidelines.org/treatment-naive/gt3/no-cirrhosis http://hcvguidelines.org/treatment-naive/gt3/compensated-cirrhosis           View Older Articles   Back to Top   www.natap.org